Cellink - Possible Breakout soon?In the latest development of Cellink, a Swedish Biotechnology company, I see the chance of a reversing trend in the form of a breakout, as a typical Head and Shoulders pattern can be found. What do you think?
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.3330 EUR
−173.48 M EUR
201.19 M EUR
43.16 M
About BICO GROUP AB
Sector
Industry
CEO
Maria Ada Eufemia Forss
Website
Headquarters
Gothenburg
Founded
2016
ISIN
SE0013647385
FIGI
BBG00RYJ2MR1
BICO Group AB engages in the provision of technologies, products, and services to create, understand, and master biology. It operates through the following segments: Bioprinting, Biosciences, Bioautomation, and Group. The Bioprinting segment includes 3D bioprinters and bioinks with a wide range of technologies for different demanding applications, resolutions, and volume and speed requirements, as well as services focused on accelerating drug discovery and development with advanced tissue imaging and cell culture services. The Biosciences segment focuses on supplying advanced lab instrumentation and smart workflow connectivity software to analyze data from applications in cell culture, cell imaging, cell sorting, and sample preparation for different analytics such as genomics. The Bioautomation segment offers scientific instruments and solutions for scalable manufacturing of diagnostics, as well as consumables to enable single-cell and other workflows. The Group segment is involved in the group’s administration and shareholder costs. The company was founded by Erik Paul Gatenholm and Hector Daniel Martinez Avila in March 2015 and is headquartered in Gothenburg, Sweden.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange CELLINK AB AK B O.N. stocks are traded under the ticker 49Z.
We've gathered analysts' opinions on CELLINK AB AK B O.N. future price: according to them, 49Z price has a max estimate of 9.23 EUR and a min estimate of 8.79 EUR. Watch 49Z chart and read a more detailed CELLINK AB AK B O.N. stock forecast: see what analysts think of CELLINK AB AK B O.N. and suggest that you do with its stocks.
Yes, you can track CELLINK AB AK B O.N. financials in yearly and quarterly reports right on TradingView.
CELLINK AB AK B O.N. is going to release the next earnings report on Feb 19, 2025. Keep track of upcoming events with our Earnings Calendar.
49Z earnings for the last quarter are −0.04 EUR per share, whereas the estimation was −0.04 EUR resulting in a 0.00% surprise. The estimated earnings for the next quarter are 0.01 EUR per share. See more details about CELLINK AB AK B O.N. earnings.
CELLINK AB AK B O.N. revenue for the last quarter amounts to 49.90 M EUR, despite the estimated figure of 49.90 M EUR. In the next quarter, revenue is expected to reach 56.37 M EUR.
49Z net income for the last quarter is −6.83 M EUR, while the quarter before that showed −2.44 M EUR of net income which accounts for −179.76% change. Track more CELLINK AB AK B O.N. financial stats to get the full picture.
No, 49Z doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CELLINK AB AK B O.N. EBITDA is 10.37 M EUR, and current EBITDA margin is 7.24%. See more stats in CELLINK AB AK B O.N. financial statements.
Like other stocks, 49Z shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CELLINK AB AK B O.N. stock right from TradingView charts — choose your broker and connect to your account.